RootsAnalysis has announced the addition of “NuclearMedicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” reportto its list of offerings
KeyMarket Insights
· Close to 130 industry and non-industryplayers, across the globe, claim to have the necessary expertise and supportinginfrastructure to manufacture a wide variety of radioisotopes, for in-houseuse, or as a contract service
· The market is fragmented, featuring thepresence of companies in both developed and developing nations, which arecapable of manufacturing radiopharmaceuticals for various applications atdifferent scales of production
· The growing interest in this field isreflected in the yearly growth in partnership activity; the majority of dealsinked in the recent past include manufacturing and supply agreements forvarious types of radiopharmaceuticals
· Stakeholders are actively expanding theircapabilities in order to enhance their respective nuclear medicine andradiopharmaceutical manufacturing capabilities and, thereby, maintain acompetitive edge in this industry
· Case Study: The decay product of Mo-99,Tc-99m, is used in majority of the radioactivity-based diagnostic applicationsin the US; reactors in the European region alone contribute to 60% of theglobal production capacity
· In the long-term, the forecasted opportunityis anticipated to be higher for radioisotopes intended for diagnosticapplications, mostly for use in the field of cardiology, with North Americaholding the dominant position
· SPECT and beta-emitters are anticipated togenerate the majority share of revenues across diagnostic and therapeuticapplications, respectively, for both in-house use and radiopharmaceuticalsupply contracts
Tableof Contents
1. PREFACE
1.1. Scopeof the Report
1.2. ResearchMethodology
1.3. ChapterOutlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. ChapterOverview
3.2. NuclearMedicines and Radiopharmaceuticals
3.3. HistoricalEvolution of Radiopharmaceuticals
3.4. Applicationsof Radiopharmaceuticals
3.4.1. Nuclear Imaging / Diagnosis
3.4.1.1. Single Photon Emission Computed Tomography
3.4.1.2. Positron Emission Tomography
3.4.2. Therapeutic Use
3.5. Productionof Radiopharmaceuticals
3.5.1. Radionuclide Generator
3.5.2. Particle Accelerator (Cyclotron)
3.5.3. Nuclear Reactor
3.6. RegulatoryFramework for Radiopharmaceuticals
3.6.1. Guidelines for the Production ofRadiopharmaceuticals
3.6.2. Guidelines for Labelling and Packaging ofRadiopharmaceuticals
3.6.3. Guidelines for Storage ofRadiopharmaceuticals
3.7. Needfor Outsourcing Radiopharmaceuticals Manufacturing
3.8. Selectinga CMO Partner for Radiopharmaceuticals Manufacturing
3.9. CurrentScenario and Future Prospects Related to Radiopharmaceuticals
4. NUCLEAR MEDICINE ANDRADIOPHARMACEUTICALS MANUFACTURERS (INDUSTRY PLAYERS): CURRENT MARKET LANDSCAPE
4.1. ChapterOverview
4.2. NuclearMedicine and Radiopharmaceuticals Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Purpose of Production
4.2.4. Analysis by Geographical Location ofHeadquarters
4.2.5. Analysis by Geographical Location ofManufacturing Facilities
4.2.6. Analysis by Scale of Production
4.2.7. Analysis by Application Area
4.2.8. Analysis by Type of Radioisotope
4.2.8.1. Radioisotopes for Diagnostic Use
4.2.8.2. Radioisotopes for Therapeutic Use
4.2.9 Analysisby Target Therapeutic Area
4.2.10 Analysisby Service(s) Offered
5. NUCLEAR MEDICINE ANDRADIOPHARMACEUTICALS MANUFACTURERS (NON-INDUSTRY PLAYERS): CURRENT MARKETLANDSCAPE
5.1. ChapterOverview
5.2. NuclearMedicine and Radiopharmaceuticals Manufacturers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Purpose of Production
5.2.3. Analysis by Geographical Location ofManufacturing Facilities
5.2.4. Analysis by Scale of Production
5.2.5. Analysis by Application Area
5.2.6. Analysis by Type of Radioisotopes
5.2.6.1. Radioisotopes for Diagnostic Use
5.2.6.2. Radioisotopes for Therapeutic Use
6. NUCLEAR MEDICINE ANDRADIOPHARMACEUTICALS MANUFACTURERS IN NORTH AMERICA
6.1. ChapterOverview
6.2. CardinalHealth
6.2.1. Company Overview
6.2.2. List of Products and Manufacturing Facilities
6.2.3. Recent Developments and Future Outlook
6.3. GEHealthcare
6.3.1. Company Overview
6.3.2. List of Products and Manufacturing Facilities
6.3.3. Recent Developments and Future Outlook
6.4. JubilantRadiopharma
6.4.1. Company Overview
6.4.2. List of Products and Manufacturing Facilities
6.4.3. Recent Developments and Future Outlook
6.5. LantheusMedical Imaging
6.5.1. Company Overview
6.5.2. List of Products and Manufacturing Facilities
6.5.3. Recent Developments and Future Outlook
6.6. Nordion
6.6.1. Company Overview
6.6.2. List of Products and Manufacturing Facilities
6.6.3. Recent Developments and Future Outlook
6.7. SOFIE
6.7.1. Company Overview
6.7.2. List of Products and Manufacturing Facilities
6.7.3. Recent Developments and Future Outlook
7. NUCLEAR MEDICINE ANDRADIOPHARMACEUTICALS MANUFACTURERS IN EUROPE
7.1. ChapterOverview
7.2. AdvancedAccelerator Applications
7.2.1. Company Overview
7.2.2. List of Products and Manufacturing Facilities
7.2.3. Recent Developments and Future Outlook
7.3. SCK•CEN
7.3.1. Company Overview
7.3.2. List of Products and Manufacturing Facilities
7.3.3. Recent Developments and Future Outlook
7.4. CuriumPharma
7.4.1. Company Overview
7.4.2. List of Products and Manufacturing Facilities
7.4.3. Recent Developments and Future Outlook
7.5. Eckert& Ziegler
7.5.1. Company Overview
7.5.2. List of Products and Manufacturing Facilities
7.5.3. Recent Developments and Future Outlook
7.6. PETNETSolutions
7.6.1. Company Overview
7.6.2. List of Products and Manufacturing Facilities
7.6.3. Recent Developments and Future Outlook
Formore information, please click on the following link:
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
